Clinical Trial 40208

share

Garden Grove, CA 92845


Study Summary:

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Risperidone Extended-Release Injectable Suspension (TV-46000) for Subcutaneous Use as Maintenance Treatment in Adult Patients with Schizophrenia


Qualified Participants Must:

• The patient has a diagnosis of schizophrenia
• The patient is a male or female of any ethnic origin, 18 through 65 years of age


Qualified Participants May Receive:

Compensation for time and travel 


Study is Available At:

CNS Network
12772 Valley View Ave, Suite 3
Garden Grove, CA 92845
View Clinic Location

 


If you or someone you care for is interested in participating in this clinical trial and lives within 50 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.